X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Idiopathic Pulmonary Fibrosis Companies

This report lists the top Idiopathic Pulmonary Fibrosis companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Idiopathic Pulmonary Fibrosis industry.

Idiopathic Pulmonary Fibrosis Top Companies

  1. Cipla Inc.

  2. Boehringer Ingelheim International GmbH

  3. F. Hoffmann-La Roche Ltd

  4. FibroGen, Inc.

  5. Horizon Therapeutics plc

*Disclaimer: Top companies sorted in no particular order

 Idiopathic Pulmonary Fibrosis Market Major Players

Idiopathic Pulmonary Fibrosis Market Concentration

Idiopathic Pulmonary Fibrosis Market Concentration

Idiopathic Pulmonary Fibrosis Company List

                              • United Therapeutics Corporation

                              • Boehringer Ingelheim International GmbH

                              • Bristol-Myers Squibb Company

                              • Cipla Inc.

                              • F. Hoffmann-La Roche Ltd

                              • FibroGen Inc.

                              • MediciNova Inc.

                              • Jubliant Pharma Limited (Jubliant Cadista Limited)

                              • Merck & Co. Inc.

                              • Horizon Therapeutics Inc.

                              • Avalyn Pharma Inc.

                              • CS Pharmaceuticals


                          Specific to Idiopathic Pulmonary Fibrosis Market
                          Need More Details On Market Players And Competitors?
                          Download Sample

                          Idiopathic Pulmonary Fibrosis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)